News & Events

Upcoming Events

Wed, 10/5/2022 - 12:00 PM ET
EGFR patients/survivors: Join us the 1st Wednesday of every month to… more
Tue, 10/11/2022 - 12:00 PM ET
For patients/survivors: Join us every Tuesday for this general meetup… more
Mon, 10/17/2022 - 12:00 PM ET
Fall series by Ben Garcia via Zoom (4 week series starting 10/17/2022… more
Tue, 10/18/2022 - 12:00 PM ET
For patients/survivors: Join us every Tuesday for this general meetup… more
Thu, 10/20/2022 - 3:00 PM ET
Join the LUNGevity Action Network team on October 20 at 3:00 pm ET… more

Caregiver Resources Starter Kit: 5 Resources Caregivers Should Access upon their Loved One’s Diagnosis

Caregiver Resources Starter Kit: 5 Resources Caregivers Should Access upon their Loved One’s Diagnosis

Navigating a lung cancer diagnosis can feel overwhelming not only to the patient but to their caregiver as well. It’s normal to feel lost or confused and not know where to start or what resources to ask for. Because a cancer diagnosis is a family diagnosis, LUNGevity wants caregivers to know they don’t have to go through it alone. There are resources available to help caregivers take care of their loved ones as well as themselves. Here are 5 important caregiver resources to help with your loved…

World Lung Cancer Day and the Changing Landscape of Lung Cancer

World Lung Cancer Day and the Changing Landscape of Lung Cancer

For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000 people in the US are diagnosed with lung cancer. The high incidence of lung cancer means scientific research into new therapies is critical, both for current survivors and those who will be diagnosed in the future. Thankfully, the landscape of lung cancer is changing for the better. Due to progress in research and…

We're Live-Tweeting from ASCO June 3-7!

We're Live-Tweeting from ASCO June 3-7!

LUNGevity’s Dr. Upal Basu Roy and Dr. Amy Moore will be live-tweeting from the American Society of Clinical Oncology (ASCO) annual meeting. Follow LUNGevity on Twitter and the hashtags #ASCO22 and #LCSM to be a part of the action. Times and topics of live-tweeted sessions are as follows: Fri, Jun 3, 2022 | 2:00 PM – 5:00 PM EDT | Lung Cancer—Non-Small Cell Metastatic  Sun, Jun 5, 2022 | 9:00 AM – 10:15 AM EDT | Treatment Sequencing in Resectable Lung Cancer…

New Options in Adjuvant Therapy for Early-Stage NSCLC

New Options in Adjuvant Therapy for Early-Stage NSCLC

Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the development of minimally invasive techniques (such as video-assisted thoracoscopic surgery or VATS), have made surgeries safer for patients, the ability to cure early-stage NSCLC patients hasn’t improved significantly in recent decades. Even after successful surgeries that completely remove the visible tumor, about half of…

Studying Drug Resistance From a New Angle

Studying Drug Resistance From a New Angle

The development of “targeted therapies” which block the function of mutant proteins within tumor cells has revolutionized the treatment landscape for many cancers, most of all lung cancer. EGFR is one such protein which is often altered (mutated) in lung cancers. Over the past decade, multiple EGFR targeted therapies have been developed, with each generation of drugs becoming increasingly potent. At present, patients with advanced EGFR-mutated lung cancer are treated with osimertinib (Tagrisso…

Highlights of the 2022 AACR meeting

Highlights of the 2022 AACR meeting

The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in person to make this year’s meeting one of the largest gatherings since the start of the pandemic. They shared the many exciting developments in cancer research and treatment that emerged over the last year. This year’s meeting is another testament to “Science doesn’t stop, and scientists never sleep!” Here, we discuss…